The dawn of immunotherapy for breast cancer
Emens, L.A.
Clinical Advances in Hematology and Oncology H&o 17(6): 332-335
2019
ISSN/ISBN: 1543-0790 PMID: 31437135 Document Number: 698519
Document emailed within 1 workday
Related Documents
Minev, B.R.; Guo, F.; Gueorguieva, I.; Kaiser, H.E. 2002: Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects In Vivo 16(6): 405-415Lüftner, D.; Pollmann, D.; Schildhauer, S.; Sehouli, J.; Possinger, K. 2005: Perspectives of immunotherapy in metastatic breast cancer Anticancer Research 25(6c): 4599-4604
Sugie, T. 2012: Today and future perspectives in breast cancer immunotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 715-719
Polevaia, E.B.; Derevnina, N.A.; Trubchaninova, L.P.; Veskova, T.K. 1988: Immunotherapy with decaris in the early stages of breast cancer Voprosy Onkologii 34(10): 1182-1188
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Kubo, M.; Morisaki, T.; Kuroki, H.; Tasaki, A.; Yamanaka, N.; Matsumoto, K.; Nakamura, K.; Onishi, H.; Baba, E.; Katano, M. 2003: Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer Anticancer Research 23(6a): 4443-4449
Saha, K.; Kapila, H.; Madan, R.; Shinghal, R.N. 1986: Immunologic tools to decipher efficacy of BCG immunotherapy in advanced breast cancer: a one year follow up study Asian Pacific Journal of Allergy and Immunology 4(2): 139-148
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Sega, E.; Castelli, M.; Sega, F.M. 1982: Carcinoma of the breast. Immunobiology and immunotherapy Minerva Ginecologica 34(11): 981-984
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82